Contractility: Cuff Versus Urodynamics Testing In Males With Voiding Lower Urinary Tract Symptoms
CONCUR
1 other identifier
interventional
50
1 country
1
Brief Summary
A number of men will experience bothersome urinary symptoms, which become more common as they age. A number of conditions can cause these symptoms, and general practitioners may refer men to their local hospital for further assessment and treatment. Symptoms can include poor flow of urine, the need to pass urine more frequently, or the sensation that the bladder is not completely emptying. This can be due to an enlargement of the prostate gland. These symptoms can also be caused when the bladder muscle is not able to contract (squeeze) as well as it previously has to empty the bladder. This is known as underactive bladder (UAB). It is important to distinguish between the two conditions as a cause for these symptoms, to prevent side effects from unnecessary medications or operations. Currently, men would need to undergo a bladder pressure test (urodynamics). This involves inserting a catheter via the penis into the bladder, through which the bladder is filled with fluid and pressure is measured. A separate second small tube is inserted into the rectum to measure the pressure in the abdomen. The pressure changes are observed as the bladder is filled, and then urine is passed around the catheter. A second technique for measuring bladder pressure is the use of a small inflatable cuff which is placed around the penis (penile cuff test). The bladder pressure can then be determined by inflating the cuff and interrupting the flow of urine. The bladder can be filled naturally before the test, which means a bladder catheter tube is not required. This study is designed to find out ways that the penile cuff test can be made more accurate. It will compare the cuff results to those obtained from a bladder pressure test, and will take x-ray pictures of the urinary tract during the test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2018
CompletedFirst Posted
Study publicly available on registry
July 27, 2018
CompletedStudy Start
First participant enrolled
August 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedSeptember 17, 2018
September 1, 2018
6 months
June 27, 2018
September 14, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference between invasive and non-invasive measurements
Comparison of the pressure required to interrupt urine flow (pcuff.int) and simultaneously measured isovolumetric bladder pressure (pves.isv).
During the procedure
Secondary Outcomes (6)
Change in variance
During the procedure
Assessment of bladder contractility - BCI
During the procedure
Assessment of bladder contractility - Watt's Factor
During the procedure
Quality of Life Assessment - ICIQ-MLUTS
During the procedure
Quality of Life Assessment - IPSS
During the procedure
- +1 more secondary outcomes
Study Arms (1)
Pilot group: urodynamics and cuff test
OTHERSingle-arm study with all participants undergoing cystometrogram, then cystometrogram with simultaneous penile cuff test, then penile cuff test alone
Interventions
Comparison of invasive vs non-invasive urodynamics
Eligibility Criteria
You may qualify if:
- Male aged 18 years old or over
- Referred for video urodynamics within our department
- Predominant voiding LUTS as assessed by IPSS at screening. \[The total IPSS score is out of 35, with up to 15 points for storage symptoms and 20 for voiding symptoms. If voiding symptoms as a percentage of total score is higher than storage symptoms they will be included in the study\].
- Capacity to understand study procedures and give informed consent
- At least 2 voided volumes on frequency volume chart (FVC) of 250 mL
You may not qualify if:
- Female patients
- Long term catheterisation
- Predominant storage LUTS on IPSS at screening
- Fewer than 2 voids on FVC \> 250 mL
- Known pre-existing neurological cause for symptoms
- Active urinary tract infection (UTI)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle, Tyne and Wear, NE7 7DN, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Helen C Morton, MBBS
Newcastle upon Tyne Hospitals NHS Foundation Trust
- STUDY DIRECTOR
Chris K Harding, MBBChir, MD
Newcastle upon Tyne Hospitals NHS Foundation Trust
- STUDY DIRECTOR
Alison Bray, PhD
Newcastle upon Tyne Hospitals NHS Foundation Trust
- STUDY DIRECTOR
James Blake, PhD
Newcastle upon Tyne Hospitals NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2018
First Posted
July 27, 2018
Study Start
August 28, 2018
Primary Completion
March 1, 2019
Study Completion
March 1, 2019
Last Updated
September 17, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share